WKL Wolters Kluwer NV

The Healthcare Technology Report Names Dr. Denise Basow of Wolters Kluwer to Top 25 Women Leaders in Healthcare Software

, a leading global provider of trusted clinical technology and evidence-based solutions, today announced that Denise Basow, MD, CEO for Clinical Effectiveness, has been ranked among the , an award given by The Healthcare Technology Report.

According to , the Top 25 honor recognizes “women leaders who exemplify achievement in a hyper-competitive industry that seeks to have profound impact across national and global communities. The importance of their leadership roles is paramount particularly as healthcare providers increasingly rely on data and technology to improve the way care is delivered. By dedicating themselves to their chosen field, through decades of expanding expertise and capabilities, these are the women leaders most respected and admired in healthcare software.”

“It is an honor to receive this award and I share this recognition with all the women leaders in our organization,” said Dr. Basow. “In these challenging times, we redouble our commitment to the hard-working doctors, nurses, pharmacists and the many clinicians on the front lines of the COVID-19 pandemic to ensure they have the best available evidence to care for their patients.”

As President and CEO for Clinical Effectiveness at Wolters Kluwer, Health, Dr. Basow leads a global organization helping hospitals and health systems improve care with acclaimed expert solutions including ®, ®, ® and ®. Previously, Dr. Basow served as Vice President and General Manager, Clinical Decision Support. As a primary care physician who joined UpToDate in 1996, Dr. Basow has also held the positions of Deputy Editor, Executive Editor and Editor-in-Chief.

Dr. Basow is board-certified in Internal Medicine. She received a BA in Chemistry from Duke University, attended Baylor College of Medicine and completed her internal medicine residency at Johns Hopkins.

To learn more about the awards, please visit:

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit and follow us on and Twitter .

For more information, visit , follow us on , , , and .

EN
08/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Wolters Kluwer NV

Wolters Kluwers: 1 director

A director at Wolters Kluwers maiden bought 1,875 shares at 131.520USD and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

 PRESS RELEASE

Share Buyback Transaction Details August 7 – August 13, 2025

Share Buyback Transaction Details August 7 – August 13, 2025 PRESS RELEASE                                         Share Buyback Transaction Details August 7 – August 13, 2025 Alphen aan den Rijn – August 14, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 137,900 of its own ordinary shares in the period from August 7, 2025, up to and including August 13, 2025, for €16.2 million and at an average share price of €117.75. These repurchases are part of the share buyback program announc...

 PRESS RELEASE

Share Buyback Transaction Details July 31 – August 6, 2025

Share Buyback Transaction Details July 31 – August 6, 2025 PRESS RELEASE                                         Share Buyback Transaction Details July 31 – August 6, 2025 Alphen aan den Rijn – August 7, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 109,700 of its own ordinary shares in the period from July 31, 2025, up to and including August 6, 2025, for €14.5 million and at an average share price of €132.48. These repurchases are part of the share buyback program announced on...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

CTP: Good results, continuation of strong demand dynamics. KBC: 2025 outlook, strong uplift post 2Q. RELX, Wolters Kluwer: Thomson Reuters 2Q25 results. SBM Offshore: Guidance up, one-offs play a role. Xior Student Housing: On track, continued focus on pricing and pipeline

David Vagman ... (+5)
  • David Vagman
  • CFA
  • Marc Hesselink
  • CFA
  • Thymen Rundberg

Wolters Kluwer/Solid start to the year/BUY

Wolters Kluwer reported a solid 1H25 update. We make small adjustments to our organic growth and margin forecasts, but it is mainly FX headwinds that bring down our top-line estimates by low-single-digit percentages in the coming years. We reiterate our BUY rating and lower our target price per share to €173 (from €178).

ResearchPool Subscriptions

Get the most out of your insights

Get in touch